Lyonbiopôle Auvergne-Rhône-Alpes’ Post

Ik Big news: Announcement of Collaboration with Withings and CSEM Under Granted Eurostars Project! Praxa Sense is proud to announce that it has received a Eurostars grant to support a three-year collaboration with Withings, a leader in connected health devices, and CSEM, a Swiss innovation center. With a total project budget of €2 million, of which approximately €800,000 is funded by EUREKA, this partnership will drive the future of cardiovascular health monitoring. About the SPECTRA Project The SPECTRA project aims to combine cutting-edge sensor technology with advanced algorithms to deliver new insights into cardiovascular health with minimal user burden. The project focuses on two key areas: 1. An innovative remote patient monitoring device with the integrated ALIS™ system. 2. Development of a Cardiovascular Risk Index algorithm. The outcomes of the SPECTRA project will represent a significant leap forward in remote health monitoring. With these innovations, Praxa Sense aims to revolutionize real-time monitoring of cardiovascular health. We are deeply grateful to Withings and CSEM for their confidence in the technical potential of the ALIS™ system. Special thanks also to EUREKA for supporting this shared vision of innovation and improved healthcare. 🚀 All three companies were exhibiting their technology beginning of January at CES in Las Vegas, where Praxa Sense demonstrated its ALIS™ Research Product for the first time, allowing visitors to not only measure the traditional PPG signal (Blood Volume), but also see the new Blood Flow index signal (Blood Velocity). The appended photo shows the following people at CES2025: Cas Bramer, Technical Lead Praxa Sense Constantijn Van Oranje-Nassau, Techleap François Vailland, Withings Leonard Moonen, CEO Praxa Sense Paulo Augusto Dal Fabbro, CSEM Corien Staels, CCO Praxa Sense #collaboration #heartfailure #ALIS #sensor #Eurostars

👩🏼⚕️Healthcare is facing enormous challenges, not least of all how to maintain the best quality at an affordable price. #Innovation by members of MEDVIA will be crucial to this intersection of priorities! So we join Provincie Oost-Vlaanderen and Provincie Vlaams-Brabant in inviting your organization to the participatory lab Photonics in Health. 📅 9 October ⏰ 16.30-18.00 🏢 Jacques Delors Building 🌐 Rue Belliard 99, Brussels 🌈 #Photonics is gaining importance as a promising field of #research, with huge potential in #health-related applications. We can support this by bringing #researchers, #innovators, #providers and #policymakers together. 🇪🇺 The event, also hosted by Provincie Noord-Brabant & Think East Netherlands, is part of the European Week of Regions and Cities, the biggest annual #Brussels-based event dedicated to cohesion policy. All #EURegionsWeek are free, but registration is required ⬇ https://lnkd.in/ebWxqKTM #healthinnovation

The IHE North America Connectathon Week in Canada showcases cutting-edge advancements in healthcare interoperability and the transformative potential of FHIR (Fast Healthcare Interoperability Resources). This premier event brings together industry leaders, developers, and implementers to collaborate on testing and advancing healthcare standards. Focusing on real-world applications, the Connectathon empowers organizations to drive seamless data exchange and innovation across the healthcare ecosystem.

🌟 Attending an Incredible Talk on the Future of Health Tech! 🌟 Last night, I had the privilege of attending a truly fascinating event at the NYUAD Institute: “Inside the Body’s Future: How Bio-NanoThings Will Change Disease Detection” presented by the esteemed Professor Ian F. Akyildiz President & CTO of Truva Inc. Imagine a future where tiny devices in your body can detect diseases at the cellular level and instantly alert your doctor—this is the promise of the Internet of Bio-NanoThings (IoBNT). We were introduced to PANACEA, a pioneering system leveraging Bio-NanoThings, tiny submillimeter devices capable of detecting infection levels within the body and transmitting real-time data to external hubs. This groundbreaking technology merges biological communication with advanced network systems, enabling a seamless, remote healthcare experience. The potential impact? Earlier detection, faster response times, and improved disease management, especially for infectious diseases. The possibilities are endless, and I left inspired by this vision of a smarter, more responsive healthcare system. If you’re curious about the future of disease detection and digital health, I highly recommend diving into the world of IoBNT and keeping an eye on what innovators like Ian Akyildiz and PANACEA are doing. Exciting times ahead! Dr. VISHNU Vijay Kumar (IITM-NUS) New York University Abu Dhabi #HealthTech #IoBNT #BioNanoThings #DiseaseDetection #Innovation #NYUAD

Dr. Google --> Your Mirror is seeing you now... 🌟 Exciting Times at HLTH Europe in Amsterdam! 🌟 Last week, we had the incredible opportunity to attend the HLTH conference in Amsterdam, and it was nothing short of inspiring! As a direct-to-consumer diagnostics company, we found this event particularly valuable for several reasons: 1. Focus on Women’s Health: The women’s health chapter, led by Paula Bellostas Muguerza KEARNEY's Global Healthcare & Life Sciences Practice Leader, highlighted a critical issue: the lack of data to accurately describe the biological situation of women, especially in clinical trials. This resonates deeply with us, and we're committed to digging deeper into our own dataset to better understand and address these disparities. Karen Madden Geraldine O'Keeffe 2. Advancements in Digital Health: The discussions on digital health were eye-opening, showcasing the latest innovations and technologies transforming the healthcare landscape. From telemedicine to wearable devices, the future of healthcare is digital, and we are excited to integrate these advancements into our diagnostic services. Dr. Anne Sophie Geier Hadas Bitran Rabea Knorr Gustave Ronteix 3. Decentralized Clinical Trials: The move towards decentralized clinical trials is a game-changer, making research more accessible and inclusive. This aligns with our mission to bring diagnostics closer to consumers, ensuring that more people can participate in and benefit from clinical research. Pooja Sikka The HLTH conference reaffirmed our commitment to leveraging data and technology to improve health outcomes. We are more motivated than ever to continue our work in providing accessible, accurate, and comprehensive diagnostic solutions. Let’s drive innovation in healthcare together! 💪🧬 #HLTH2024 #WomensHealth #DigitalHealth #DecentralizedTrials #HealthcareInnovation #Diagnostics #DataDrivenHealth #FutureOfHealthcare Aquil Harjivan Holger Lenz

Reflecting on Rebuild Ukraine Health 2024: Innovations and Collaborations in Healthcare I recently had the privilege of attending the ReBuild Ukraine: Health & Rehabilitation conference, and I'm inspired by the wealth of ideas and collaborations that emerged. The event showcased the resilience and forward-thinking mindset driving Ukraine's recovery and growth, particularly in the healthcare sector. Never before have I had tears at a conference. But not this time. At the intersection of emotions – I rejoice that we are in a niche aimed at real change in this world, but at the same time, it is not about business – it’s about pain and recovery. On one side, urban/district hospitals present their projects for investment, on the other – beautiful and traditionally bright stands of international equipment manufacturers, but medical equipment. New acquaintances with doctors, with Ukraine's medical ecosystem. I am impressed by the dreams, projects, and innovations that the Ukrainian medical world is preparing, understanding, and implementing. An unexpected pitch on camera for an American consortium that we initiated with Superhumans back in December – data in prosthetics. Potential development of a sensor that will allow us to track the progress of veterans' rehabilitation with prosthetics for 5+ months. Powerful. I'm excited about the potential projects and partnerships that can stem from these conversations. At VITA325, we're committed to leveraging AI and data to enhance healthcare outcomes. Collaborations with international experts will be instrumental in achieving our goals. Thank you to all the organizers, speakers, and participants for an enlightening experience. Together, we can build a healthier future for Ukraine and beyond. Let's keep the momentum going! 🚀 #RebuildUkraineHealth #HealthcareInnovation #AIinHealthcare #Prosthetics #Telemedicine #Collaboration #Vita325

Reflecting on the insightful panel discussion at the #LIFESAVER Conference on June 13th, hosted by i3S,Porto in Portugal. We delved into the current challenges and emerging innovations in Maternal-Fetal Healthcare with a stellar lineup of experts. 🎤 Panelists included: - Michael Gasik (SEQ) - André Albergaria (i3S) - Gracinda Duarte (BlueClinical) - Sandra Rebelo and Carla Ramalho (CHUSJ) - Telma Barbosa (CHUSA/CMIN) - Francesco Franchini (EnginSoft Italy) 🙋♀️ Facilitated by Inês Pinto (i3S - Instituto de Investigação e Inovação em Saúde), the discussion spanned several crucial topics: - Integrating machine learning to redefine regulatory and best practices. - Exploring the potential of bio-digital twins for preclinical assessments. - Addressing data management challenges in biochemical environments. - Innovating to disrupt traditional maternal-fetal health systems. These conversations are vital as we strive to enhance healthcare outcomes through technological innovation, providing safer and more effective solutions for maternal and fetal health. #HealthTech #InnovationInHealthcare #MaternalHealth #EUCommission Ministério da Saúde de Portugal

We're thrilled to announce that James Mault, MD, FACS, Founder and CEO of BioIntelliSense, is joining the newly formed Advisory Board of M42 Health, alongside fellow health and technology luminaries David Rhew, M.D., Microsoft Global Chief Medical Officer and VP of Healthcare; David A. Sinclair A.O., Ph.D., Professor of Epigenetics and Longevity at Harvard University; and Sir Chris Evans, Chairman of Ellipses Pharma. The new M42 Advisory Board marks a critical milestone for the Abu Dhabi-based, global tech-enabled health and healthcare company with facilities in more than 26 countries. According to M42, the new Advisory Board will “drive M42’s vision to reshape the sustainable future of health through collaboration with other regional and international industry leaders. “The Advisory Board reflects M42’s commitment to bring together traditional health-tech and healthcare provisions under a holistic ‘health’ approach, focused on preventive, precise and personalized health solutions. This pioneering approach, coupled with M42’s cutting-edge innovation and commitment to reshaping the sustainable future of health, positions it as an unparalleled force in the global health sector.” Read more in today’s announcement: https://lnkd.in/gKRCV4EX #HealthcareInnovation #HealthTech #HealthcareFuture

Our Managing Director and Group CEO, Hasan Jasem Al Nowais, was recently featured in Emirates News Agency - WAM - وكالة أنباء الإمارات - وام. He shared his thoughts on how the UAE's advanced hospitals, cutting-edge robotic technologies, genomic research, and AI-driven infrastructure have set a benchmark for preventive medicine.   At this year’s Annual Longevity Forum in the UK, Hasan Al Nowais credits this progress to the UAE leadership's ambitious vision, driving the adoption of global medical advancements. M42 plays a pivotal role in this transformation, collaborating with government entities to redefine healthcare through data analytics, early health threat detection, and cost-effective targeted treatments.   M42 is championing a proactive, prevention-focused model that supports healthy aging, enhances the quality of life, and promotes sustainable healthcare. Through innovations like the AI-powered "AIRIS-TB" system, capable of analyzing 2,000 chest X-rays daily, and facilitating the Emirati Genome Programme, M42 is advancing precision and predictive medicine.   “For lasting, positive change in global healthcare, we must focus on precision, preventive, and predictive medicine,” Al Nowais emphasized, underscoring M42’s commitment to leveraging AI, genomic science, and collaborations to detect diseases early and enhance human longevity.   Click here https://bit.ly/3ZWFQfm to read more about how M42 is redefining healthcare.  The Longevity Forum   #HealthcareInnovation #AIinMedicine #PrecisionMedicine #Longevity #M42 #UAEHealthcareLeadership

🗓️Last week, Mariola Penadés, Director of Research & Innovation from GVA, visited last week the installations of COR group - ITACA. 👉The aim of this meeting was to explore cutting-edge technology to improve the results of diagnosis and treatment of atrial fibrillation and other cardiac arrhythmias. 🗣️"Our Imageless #ECGI technology revolutionises the diagnosis of arrhythmias. This technology allows the clinical team to visualise the electrical activity of the heart globally,' said Andreu M. Climent, researcher and CEO of Corify. 😃Very satisfied with the reach of our research activity and sinergies🤝.  #Healthcare #Innovation #ECGI #CardiacCare #UPV #CorifyCare